News from NORD

Running for Rare Team Participates in Boston Marathon to Raise Funds for Undiagnosed Patients


 

Braving rain, wind, and frigid conditions, the Running for Rare team of marathon runners participated in the Boston Marathon on April 16, 2018, to raise funds for NORD’s assistance program to help undiagnosed patients. For the past several years, the runners have supported NORD by participating in the Boston Marathon as well as several other full- and half-marathons. Visit the runners’ web page.

Recommended Reading

Osteogenesis Imperfecta Foundation (OIF)
MDedge Hematology and Oncology
Patidegib, the first topical hedgehog inhibitor, scores in Gorlin syndrome
MDedge Hematology and Oncology
Malignant pleural mesothelioma guidelines often are ignored
MDedge Hematology and Oncology
Maintenance chemo boosts survival for youth with high-risk rhabdomyosarcoma
MDedge Hematology and Oncology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Hematology and Oncology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Hematology and Oncology
RFPs Available for the Study of Three Rare Diseases
MDedge Hematology and Oncology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Hematology and Oncology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Hematology and Oncology
NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans
MDedge Hematology and Oncology